Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer

被引:129
作者
Cao, Yue [1 ]
Gang, Xiaokun [1 ]
Sun, Chenglin [1 ]
Wang, Guixia [1 ]
机构
[1] Jilin Univ, Hosp 1, Dept Endocrinol & Metab, Changchun 130021, Peoples R China
关键词
UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; LIMBAL EPITHELIAL TRANSPLANTATION; STROMAL CELLS; ADIPOSE-TISSUE; MULTILINEAGE DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CONDITIONED MEDIUM; GROWTH-FACTOR; THERAPY;
D O I
10.1155/2017/9328347
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Mesenchymal stem cells (MSCs), an ideal cell source for regenerative therapy with no ethical issues, play an important role in diabetic foot ulcer (DFU). Growing evidence has demonstrated that MSCs transplantation can accelerate wound closure, ameliorate clinical parameters, and avoid amputation. In this review, we clarify the mechanism of preclinical studies, as well as safety and efficacy of clinical trials in the treatment of DFU. Bone marrow-derived mesenchymal stem cells (BM-MSCs), compared with MSCs derived from other tissues, may be a suitable cell type that can provide easy, effective, and cost-efficient transplantation to treat DFU and protect patients from amputation.
引用
收藏
页数:10
相关论文
共 108 条
[21]
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[22]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[23]
The importance of limb preservation in the diabetic population [J].
Evans, Karen Kim ;
Attinger, Christopher E. ;
Al-Attar, Ali ;
Salgado, Christopher ;
Chu, Carrie K. ;
Mardini, Samir ;
Neville, Richard .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (04) :227-231
[24]
Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases [J].
Gregoire, C. ;
Lechanteur, C. ;
Briquet, A. ;
Baudoux, E. ;
Baron, F. ;
Louis, E. ;
Beguin, Y. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (02) :205-221
[25]
Hicks C. W., 2015, ANN VASCULAR SURG
[26]
The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer [J].
Hou, Chunli ;
Shen, Lei ;
Huang, Qiang ;
Mi, Jianhong ;
Wu, Yangxiao ;
Yang, Mingcan ;
Zeng, Wen ;
Li, Li ;
Chen, Wen ;
Zhu, Chuhong .
BIOMATERIALS, 2013, 34 (01) :112-120
[27]
Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke [J].
Hsuan, Yogi Chang-Yo ;
Lin, Cheng-Hsien ;
Chang, Ching-Ping ;
Lin, Mao-Tsun .
BRAIN AND BEHAVIOR, 2016, 6 (10)
[28]
Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: Proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow [J].
Hua, Jie ;
Gong, Jian ;
Meng, Hongbo ;
Xu, Bin ;
Yao, Le ;
Qian, Mingping ;
He, Zhigang ;
Zou, Shaowu ;
Zhou, Bo ;
Song, Zhenshun .
CELL BIOLOGY INTERNATIONAL, 2014, 38 (02) :198-210
[29]
The association between history of diabetic foot ulcer, perceived health and psychological distress: the Nord-Trondelag Health Study [J].
Iversen, Marjolein M. ;
Midthjell, Kristian ;
Tell, Grethe S. ;
Moum, Torbjorn ;
Ostbye, Truls ;
Nortvedt, Monica W. ;
Uhlving, Sverre ;
Hanestad, Berit R. .
BMC ENDOCRINE DISORDERS, 2009, 9
[30]
Bone Marrow Cell Mobilization by the Systemic Use of Granulocyte Colony-Stimulating Factor (GCSF) Improves Wound Bed Preparation [J].
Iwamoto, Satori ;
Lin, Xiaofeng ;
Ramirez, Ron ;
Carson, Polly ;
Fiore, David ;
Goodrich, Jane ;
Yufit, Tatyana ;
Falanga, Vincent .
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2013, 12 (04) :256-264